Bushu Pharmaceuticals Ltd.

Form 483 issued December 2, 2022 · Kawagoe, Japan

Inspection
Nov 28 – Dec 2, 2022
Investigator
Noreen Muniz
Observations
3
Pages
4
FEI number
3005709762

In short: On December 2, 2022, FDA issued a Form 483 with 3 observations to Bushu Pharmaceuticals Ltd. in Kawagoe, Saitama (FEI 3005709762) after an inspection that ran Nov 28 – Dec 2, 2022. The investigator was Noreen Muniz. Most observations concern quality system and laboratory controls.

At a glance

Quality system and laboratory controls account for 2 of 3 observations.

Quality system1
Laboratory controls1
Facilities & equipment1

What FDA observed

Preview: the opening words of each observation
  1. 01

    The responsibilities and procedures applicable to the quality control unit are not in…

  2. 02

    Established test procedures and laboratory control mechanisms are not followed and documented at…

  3. 03

    The separate or defined areas and control systems necessary to prevent contamination…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Bushu Pharmaceuticals Ltd.?

FDA listed 3 observations on this Form 483, mostly about quality system, laboratory controls and facilities & equipment. The opening words of each observation are shown on this page.

Who inspected Bushu Pharmaceuticals Ltd.?

Noreen Muniz is named on this Form 483, for the inspection of Nov 28 – Dec 2, 2022. Each investigator has a profile showing what they cite most.

When was Bushu Pharmaceuticals Ltd. inspected by FDA?

The inspection ran Nov 28 – Dec 2, 2022, and the Form 483 is dated December 2, 2022.

How do I get the full Form 483 for Bushu Pharmaceuticals Ltd.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free